Thierry Jacquemin
Internal Medicine · Miami, FLNPI 1750407086
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Lilly USA, LLC at 49.0% of the total.
Across 34 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$312
- Novo Nordisk$95
- Hologic Sales And Service, LLC$67
- Acella Pharmaceuticals, LLC$34
- Intra-sana Laboratories$28
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$24
- plus $76 from 4 others
Across 112 payments — averaging $25,686 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$1.4M
- Taro Pharmaceuticals USA, Inc.$632K
- Acella Pharmaceuticals, LLC$358K
- Sun Pharmaceutical Industries Inc.$211K
- Bausch Health US, LLC$78K
- Avion Pharmaceuticals$76K
- plus $81K from 2 others
What the payments were for
- Food & beverage$636100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $312 |
| Novo Nordisk | 5 | $95 |
| Hologic Sales And Service, LLC | 3 | $67 |
| Acella Pharmaceuticals, LLC | 2 | $34 |
| Intra-sana Laboratories | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| CSL Behring | 1 | $22 |
| Abbott | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
How this compares
$636 in reported general payments places this provider in the 60th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Miami
- Haytham ElgammalMiami$2.2M
- Richard AguilarMiami$239K
- Maria Delgado LelievreMiami$80K
- Marlow HernandezMiami$58K
- Steven CohnMiami$47K
- Joseph PiperatoMiami$45K
- Simon AbelsonMiami$44K
- Joel Brooks TamayoMiami$42K
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.